Literature DB >> 6851403

Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine.

A J Scriven, C T Dollery, M B Murphy, I Macquin, M J Brown.   

Abstract

To determine whether small changes in sympathetic activity would cause detectable changes in plasma norepinephrine (NE) levels, and whether the effects of endogenously released and exogenous NE differ, we injected tyramine infusions and l-norepinephrine (l-NE), into six healthy subjects, and the changes in blood pressure (BP) and plasma NE were related. The mean increase in systolic BP was approximately 17 mm Hg with both infusions; diastolic BP increased with l-NE but did not rise significantly with tyramine. Heart rate fell more with l-NE than with tyramine infusions. The maximum increase in plasma NE levels was more than 500% during l-NE infusions but less than 200% with tyramine. There was no correlation between plasma NE and absolute levels of systolic BP when individual data were plotted for tyramine infusions, whereas mean group changes in systolic BP correlated strongly with mean group plasma NE, both during tyramine and l-NE infusions. The slope of the relationship was much steeper for tyramine than for l-NE. We conclude that the use of plasma NE to measure small differences in sympathetic activity among individuals is limited by interindividual variability, whereas changes in sympathetic activity within groups are more likely to be detected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851403     DOI: 10.1038/clpt.1983.97

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

2.  Dopamine contamination of infused tyramine.

Authors:  Courtney Holmes; Jeffrey Moak; Basil Eldadah; Ella Zimmerly; Yehonatan Sharabi; David S Goldstein
Journal:  Clin Chem       Date:  2005-07-21       Impact factor: 8.327

3.  Neuronal source of plasma dopamine.

Authors:  David S Goldstein; Courtney Holmes
Journal:  Clin Chem       Date:  2008-09-18       Impact factor: 8.327

4.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

5.  Interstitial noradrenaline concentration of rat hearts as influenced by cellular catecholamine uptake mechanisms.

Authors:  O O Obst; M C Linssen; G J Van der Vusse; H Kammermeier
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 6.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

7.  Beta-blockade antagonism of tyramine-induced rise in blood pressure.

Authors:  F Colombo; R Sega; F Mailland; R Rigo; L Palvarini; A Libretti
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.

Authors:  Maple M Fung; Carie Nguyen; Parag Mehtani; Rany M Salem; Brandon Perez; Brenda Thomas; Madhusudan Das; Nicholas J Schork; Sushil K Mahata; Michael G Ziegler; Daniel T O'Connor
Journal:  Circulation       Date:  2008-01-07       Impact factor: 29.690

9.  The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man.

Authors:  P H Seidelin; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 10.  Roles of catechol neurochemistry in autonomic function testing.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-04-28       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.